Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating mesenchymal stem cell therapy for late-stage AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Cell Energy Life Sciences Group Co. LTD | Conditions: AIDS | Phase 1, Phase 2 | Status: RECRUITING